Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 23991383)

1.

Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features.

Sethi S, Pushker N, Kashyap S, Sharma S, Mehta M, Bakhshi S, Khurana S, Ghose S.

Int J Ophthalmol. 2013 Aug 18;6(4):481-6. doi: 10.3980/j.issn.2222-3959.2013.04.14. eCollection 2013.

2.

Clinical presentation and survival of retinoblastoma in Indian children.

Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM.

Br J Ophthalmol. 2015 Jun 10. pii: bjophthalmol-2015-306672. doi: 10.1136/bjophthalmol-2015-306672. [Epub ahead of print]

PMID:
26061162
3.

A clinical study of retinoblastoma.

Subha L, Reddy AS, Ramyaa.

J Pharm Bioallied Sci. 2015 Apr;7(Suppl 1):S2-3. doi: 10.4103/0975-7406.155761.

4.

Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.

Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW.

Br J Ophthalmol. 2015 Apr 14. pii: bjophthalmol-2014-306364. doi: 10.1136/bjophthalmol-2014-306364. [Epub ahead of print]

PMID:
25873648
5.

Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.

Künkele A, Wilm J, Holdt M, Lohmann D, Bornfeld N, Eggert A, Temming P, Schulte JH.

Br J Ophthalmol. 2015 Jul;99(7):949-53. doi: 10.1136/bjophthalmol-2014-306222. Epub 2015 Jan 12.

PMID:
25583279
6.

High-risk histomorphological features in retinoblastoma and their association with p53 expression: An Indian experience.

Seema R, Parul S, Nita K; Kamlesh.

Indian J Ophthalmol. 2014 Nov;62(11):1069-1071. doi: 10.4103/0301-4738.146747.

7.

Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.

Shah PK, Narendran V, Kalpana N.

Ophthalmic Genet. 2013 Dec 30. [Epub ahead of print]

PMID:
24372404
8.

Retinoblastoma presenting with orbital cellulitis.

Walinjkar J, Krishnakumar S, Gopal L, Ramesh A, Khetan V.

J AAPOS. 2013 Jun;17(3):282-6. doi: 10.1016/j.jaapos.2013.02.009.

PMID:
23791410
9.

Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.

Chantada GL, Sampor C, Bosaleh A, Solernou V, Fandiño A, de Dávila MT.

JAMA Ophthalmol. 2013 Sep;131(9):1127-34. doi: 10.1001/jamaophthalmol.2013.260.

PMID:
23787805
10.

Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.

Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.

J Clin Oncol. 2013 Apr 10;31(11):1458-63. doi: 10.1200/JCO.2012.42.3962. Epub 2013 Mar 4.

11.

High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.

Kaliki S, Shields CL, Rojanaporn D, Al-Dahmash S, McLaughlin JP, Shields JA, Eagle RC Jr.

Ophthalmology. 2013 May;120(5):997-1003. doi: 10.1016/j.ophtha.2012.10.044. Epub 2013 Feb 8.

PMID:
23399379
12.

Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.

Khurana A, Eisenhut CA, Wan W, Ebrahimi KB, Patel C, O'Brien JM, Yeom K, Daldrup-Link HE.

Eur Radiol. 2013 May;23(5):1271-80. doi: 10.1007/s00330-012-2707-8. Epub 2012 Nov 18.

PMID:
23160663
13.

MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).

Radhakrishnan V, Sharma S, Vishnubhatla S, Bakhshi S.

Br J Ophthalmol. 2013 Jan;97(1):52-8. doi: 10.1136/bjophthalmol-2012-301977. Epub 2012 Oct 31.

PMID:
23117972
14.

Current therapy and recent advances in the management of retinoblastoma.

Meel R, Radhakrishnan V, Bakhshi S.

Indian J Med Paediatr Oncol. 2012 Apr;33(2):80-8. doi: 10.4103/0971-5851.99731.

15.

Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran.

Nabie R, Taheri N, Fard AM, Fouladi RF.

Int J Ophthalmol. 2012;5(4):510-2. doi: 10.3980/j.issn.2222-3959.2012.04.20. Epub 2012 Aug 18.

16.

Clinical presentation of retinoblastoma in Malaysia: a review of 64 patients.

Reddy SC, Anusya S.

Int J Ophthalmol. 2010;3(1):64-8. doi: 10.3980/j.issn.2222-3959.2010.01.15. Epub 2010 Mar 18.

17.

Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.

Radhakrishnan V, Kashyap S, Pushker N, Sharma S, Pathy S, Mohanti BK, Vishnubhatla S, Ghose S, Bakhshi S.

Ophthalmology. 2012 Jul;119(7):1470-7. doi: 10.1016/j.ophtha.2012.01.029. Epub 2012 Mar 28.

PMID:
22463820
18.

Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.

Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M.

Br J Ophthalmol. 2012 Aug;96(8):1084-7. doi: 10.1136/bjophthalmol-2011-301016. Epub 2012 Feb 24.

PMID:
22368262
19.

Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.

Smith SJ, Pulido JS, Salomão DR, Smith BD, Mohney B.

Br J Ophthalmol. 2012 Aug;96(8):1073-7. doi: 10.1136/bjophthalmol-2011-300829. Epub 2012 Feb 24.

PMID:
22368261
20.

Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.

Marr BP, Dunkel IJ, Linker A, Abramson DH.

Br J Ophthalmol. 2012 Jun;96(6):881-3. doi: 10.1136/bjophthalmol-2011-300517. Epub 2012 Feb 10.

PMID:
22328819
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk